2008
DOI: 10.3171/foc/2008/24/3-4/e20
|View full text |Cite
|
Sign up to set email alerts
|

Stem cell–mediated regeneration of the intervertebral disc: cellular and molecular challenges

Abstract: ✓ Regenerative medicine and stem cells hold great promise for intervertebral disc (IVD) disease. The therapeutic implications of utilizing stem cells to repair degenerated discs and treat back pain are highly anticipated by both the clinical and scientific communities. Although the avascular environment of the IVD poses a challenge for stem cell–mediated regeneration, neuroprogenitor cells have been discovered within degenerated discs, allowing scientists to revisit the hostile environment of the IVD a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 28 publications
1
14
0
Order By: Relevance
“…Although maintenance and regulation of proteoglycan synthesis is also critical within the nucleus pulposus, we have chosen annulus cells here because of our specific interest in development of clinically appropriate future biologic therapies for disc degeneration, especially those that might employ autologous disc and MSC or AD-MSC therapies. [27][28][29][30][31][32][33][34] We concur with An et al and others that for clinical applications, research on the annulus is a logical first step since no therapeutic methods for the nucleus would be likely to be successful in the environment of a compromised annulus tissue. 35,36 Ultimately, it is the ECM of the annulus that fails in disc degeneration; dehydration and matrix fraying culminate in the formation of tears within the …”
Section: Discussionsupporting
confidence: 77%
“…Although maintenance and regulation of proteoglycan synthesis is also critical within the nucleus pulposus, we have chosen annulus cells here because of our specific interest in development of clinically appropriate future biologic therapies for disc degeneration, especially those that might employ autologous disc and MSC or AD-MSC therapies. [27][28][29][30][31][32][33][34] We concur with An et al and others that for clinical applications, research on the annulus is a logical first step since no therapeutic methods for the nucleus would be likely to be successful in the environment of a compromised annulus tissue. 35,36 Ultimately, it is the ECM of the annulus that fails in disc degeneration; dehydration and matrix fraying culminate in the formation of tears within the …”
Section: Discussionsupporting
confidence: 77%
“…Oocytes are also surrounded by an extensive HA coat which is depolymerised post-fertilization this is a relatively poorly researched area of ECM remodeling however with scant details available on how this actually occurs. The human genome contains 6 hyaluronidase-like genes Hyal1, Hyal2, Hyal3, Hyal4, HyalP1 and PH20 [51]. HyalP1 is an inactive pseudogene and PH20 is a testicular enzyme.…”
Section: Spine Research Issn 2471-8173mentioning
confidence: 99%
“…Chondrocytes and cells from the central regions of the disc normally produce these matrix proteins, making them candidates for cell-based disc repair. Moreover, development of stem cell research in the past decade provides an attractive prospect of adult MSCs for NP tissue engineering [23,25,27,44,49,50,54,56,61,64].The study of MSCs was initiated by Friedenstein and colleagues [15] more than 40 years ago. So far it has been well recognized that MSCs have the ability to differentiate along various lineages of mesenchymal origin, including chondrocyte, osteoblast, and adipocyte lineages, depending upon the biological environment, and can be obtained from multiple adult tissues such as bone marrow, trabecular bone, articular cartilage, muscle, and adipose [6].…”
Section: Cellsmentioning
confidence: 99%
“…Treatment of disc degeneration remains still a great challenge to both clinical physicians and basic researchers. As a biological treatment strategy, tissue engineering approach has received considerable attention during the last decade, and the achievements and challenges in this field have been well documented in several reviews [25,27,44,46].…”
Section: Introductionmentioning
confidence: 99%